Immunomedics Inc (NASDAQ:IMMU)

4.14
Delayed Data
As of Mar 03
 -0.015 / -0.36%
Today’s Change
3.04
Today|||52-Week Range
5.48
-13.75%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close4.16
Today’s open4.15
Day’s range-- - --
Volume613,356
Average volume (3 months)1,007,854
Market cap$388.0M
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book9.83

Competitors

 Today’s
change
Today’s
% change
ENTLEntellus Medical Inc-0.28-1.34%
LMNSLumenis Ltd-0.41-3.48%
CLDNCelladon Corp-0.12-0.63%
ARDXArdelyx Inc-1.06-6.44%
Data as of 03/03/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account